Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Fouquet, Gregory, Marcq, Ingrid, Debuysscher, Véronique, Bayry, Jagadeesh, Rabbind Singh, Amrathlal, Bengrine, Abderrahmane, Nguyen-Khac, Eric, Naassila, Mickael, Bouhlal, Hicham
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2018
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://ncbi.nlm.nih.gov/pubmed/29662641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24575
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge